Artivion AORT

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
-$0.53 (-2.14%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0

Relative Strength Index (RSI)

- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

- The RSI is calculated using the following formula:

RSI = 100 - (100 / (1 + RS))

Where RS is the ratio of the average gains to the average losses over a specified period.

- The default time period used is 14 days.

- RSI values range between 0 and 100.

RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

About

Business overview of Artivion (AORT)
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others.

Key Insights

Critical company metrics and information
  • Latest Closing Price

    $24.18
  • Market Cap

    $1.01 Billion
  • Price-Earnings Ratio

    -75.56
  • Total Outstanding Shares

    41.73 Million Shares
  • Total Employees

    1,500
  • Dividend

    $0.03 Per Share Quarterly
  • IPO Date

    February 11, 1993
  • SIC Description

    Surgical & Medical Instruments & Apparatus
  • Primary Exchange

    New York Stock Exchange
  • Type

    Common Stock
  • Headquarters

    1655 roberts boulevard n w, Kennesaw, GA, 30144
  • Homepage

    https://www.artivion.com

Historical Stock Splits

Execution DateSplit Amount
No Historical Stock Splits

Cash Flow Statement

January 1, 2024 to December 31, 2024
MetricValue
Net Cash Flow From Operating Activities$22.24 Million
Net Cash Flow From Operating Activities, Continuing$22.24 Million
Net Cash Flow, Continuing$-3.75 Million
Exchange Gains/Losses$-1.73 Million
Net Cash Flow$-5.48 Million
Net Cash Flow From Investing Activities, Continuing$-28.19 Million

Income Statement

January 1, 2024 to December 31, 2024
MetricValue
Income Tax Expense/Benefit, Deferred$-1.51 Million
Operating Expenses$209.91 Million
Research and Development$28.45 Million
Revenues$388.54 Million
Income/Loss From Continuing Operations Before Tax$-7.51 Million
Income Tax Expense/Benefit, Current$7.36 Million

Comprehensive Income

January 1, 2024 to December 31, 2024
MetricValue
Comprehensive Income/Loss Attributable To Noncontrolling Interest$0
Comprehensive Income/Loss$-26.28 Million
Comprehensive Income/Loss Attributable To Parent$-26.28 Million
Other Comprehensive Income/Loss$-26.28 Million

Balance Sheet

January 1, 2024 to December 31, 2024
MetricValue
Noncurrent Liabilities$446.08 Million
Other Current Assets$210.31 Million
Equity Attributable To Noncontrolling Interest$0
Fixed Assets$36.40 Million
Liabilities$512.90 Million
Other Current Liabilities$30.51 Million

Historical Dividends

Current dividend: $0.03 Per Share Quarterly
Announcement DatePayment DateRecord DateAmountFrequency
Oct 22, 2015Dec 18, 2015Dec 11, 2015$0.03Quarterly
Jul 22, 2015Sep 18, 2015Sep 11, 2015$0.03Quarterly
May 21, 2015Jun 19, 2015Jun 12, 2015$0.03Quarterly
Feb 13, 2015Mar 20, 2015Mar 13, 2015$0.03Quarterly
Oct 23, 2014Dec 19, 2014Dec 12, 2014$0.03Quarterly
Jul 30, 2014Sep 19, 2014Sep 12, 2014$0.03Quarterly

Recent Headlines From The Web

Latest news, press releases, and media coverage about AORT from trusted financial sources